openPR Logo
Press release

New date announced for SMi's Pharma Microbiology East Coast Conference

05-15-2020 10:13 AM CET | Health & Medicine

Press release from: SMi Group

microbiology, microbiologist, pharmaceutical microbiology, sterility, endoxtins, contamination control, environmental monitoring

microbiology, microbiologist, pharmaceutical microbiology, sterility, endoxtins, contamination control, environmental monitoring

SMi Reports: New highlighted and confirmed key speakers and agenda highlights summarised for Pharma Microbiology East Coast, which has now been postponed due to safety concerns over COVID-19, now taking place on October 28 and 29 2020, in Boston.

SMi's 3rd Annual Pharmaceutical Microbiology Conference will no longer take place this April. Instead, the conference new dates are October 28 and 29, 2020 at the Sheraton Boston Hotel, Boston, USA.

SPONSORED BY: Associates of Cape Cod, bioMerieux, Bioscience International, C.T.L. MAT, LONZA, Microbiologics, Millipore Sigma

The Conference will address the unique needs of pharmaceutical microbiologists and interdisciplinary scientists involved in manufacturing. It will also provide excellent opportunities to network, interact, exchange, as well as learn from industry experts and professionals from around the world.

Event Highlights:
o Discuss ongoing complication of personnel derived contaminations from the FDA
o Gain valuable insight towards microbiological quality considerations in non-sterile manufacturing and control of BCC from Parexel
o Learn from the perspective of the US Pharmacopeia on container closure integrity evaluation
o Examine an end-to-end contamination risk assessment for autologous cell therapy from Bristol-Myers Squibb
o Explore a back to back Genentech session covering technical considerations for microbial QC of raw materials used in biotechnology and the past, current and future state of Mycoplasma testing

Highlighted and new confirmed key speakers for 2020:
o Elia Sanchez, QC Microbiology Sr. Manager, Genentech
o Kenneth Tai, QC Scientist, Genentech
o Michael Song, Senior Manager, MedImmune
o Hilary Chan, Principal QC Scientist, Takeda
o Maria Dunnells, Sr. Manufacturing Lead Investigator, Takeda
o Austin Kuo, Principal Research Scientist, Sterility Assurance, Eli Lilly and Company
o Jim Polarine, Senior Technical Service Manager, STERIS Corporation
o Steve Walton, Sr Sterility Assurance Lead, Baxter International
o Lakiya Wimbish, Product Manager, Lonza
o Kashyap Bhatt, Senior QA Auditor, Ipsen
o Shabnam Solati, CEO, CTL-MAT
o Veronika Wills, Manager, Technical Services, Associates of Cape Cod
o Brendan Tindall, Global Solutions Manager and Program Director, bioMerieux
o Renate Rosengarten, Professor and Chair of Bacteriology and Hygiene, University of Veterinary Medicine Vienna/ Mycosafe Consulting

SMi is pleased to announce two keynote speakers joining us, Marra Jose Lopez Barragan, CMC Product Quality Reviewer, FDA and Leslie Furr, Associate Scientific Liaison, US Pharmacopeia

There are also two interactive workshops taking place on October 30, 2020 at the Sheraton Boston hotel, USA. The two workshops are on:

Workshop A - Recombinant chromogenic assay as alternate methods for the bacterial endotoxins test (bet).
Workshop B- Mycoplasma testing by anyone, anywhere and anytime!

A new brochure with full sessions and speakers is available on event website and for those interested in attending, registration is available at www.microbiologyeastcoast.com/pr6

SPONSORED BY: Associates of Cape Cod, bioMerieux, Bioscience International, C.T.L. MAT, LONZA, Microbiologics, Millipore Sigma
For sponsorship enquiries contact Alia Malick on +44 (0)20 7827 6164 or amalick@smi-online.co.uk

For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6000 or ssapal@smi-online.co.uk

Pharmaceutical Microbiology East Coast 2020
Conference: October 28th-29th, 2020
Workshops: October 30th, 2020
Sheraton Boston Hotel, Boston, USA
http://www.microbiologyeastcoast.com/pr6
#SMiPharmaMicroEC

SMi Group
45 Curlew Street
London
SE1 2ND

About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release New date announced for SMi's Pharma Microbiology East Coast Conference here

News-ID: 2046861 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the